Inactive Instrument

Advanced Oncotherapy PLC Stock price London S.E.

Equities

GB00B16JQ761

Advanced Medical Equipment & Technology

End-of-day quote London S.E.
- GBX 0.00% Intraday chart for Advanced Oncotherapy PLC
Sales 2020 - Sales 2021 - Capitalization 172M
Net income 2020 -25M Net income 2021 -29M EV / Sales 2020 -
Net Debt 2020 48.32M Net Debt 2021 49.09M EV / Sales 2021 -
P/E ratio 2020
-4.11 x
P/E ratio 2021
-4.93 x
Employees -
Yield 2020 *
-
Yield 2021
-
Free-Float 52.47%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 49 14-08-26
Director of Finance/CFO - 16-09-30
Chairman 82 06-06-15
Members of the board TitleAgeSince
Director/Board Member 64 20-09-28
Chairman 82 06-06-15
Director/Board Member 74 17-01-25
More insiders
Advanced Oncotherapy Plc is a United Kingdom-based specialist developer and provider of a proton therapy system, the LIGHT system. The Company's team, ADAM, based in Geneva, is focused on the development of a proprietary proton accelerator called, Linac Image Guided Hadron Technology (LIGHT). LIGHT's compact configuration delivers proton beams in a way that facilitates greater precision and electronic control. The linear design of LIGHT allows for active longitudinal modulation along the proton beam axis and the variation of the proton beam by electronic means during cancer treatment. The modular feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. Its subsidiaries include ADAM S.A., Advanced Oncotherapy Americas Inc, Advanced Oncotherapy B.V., Advanced Oncotherapy Resources Ltd, APTS Harley Street Ltd, Advanced Oncotherapy (China) Ltd, Advanced Oncotherapy Proton Therapy Services Ltd and other.
More about the company
  1. Stock
  2. Equities
  3. Stock Advanced Oncotherapy plc
  4. Stock Advanced Oncotherapy PLC - London S.E.